Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Stanford University
- Study ID
- NCT02889016
- Status
- Recruiting
Conditions
- PANDAS
- PANS
- Pediatric Acute-Onset Neuropsychiatric Syndrome
- Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - 18 Years
- Healthy Volunteers
- Accepted
Study Details
This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and urinary frequency. PANS is thought to be caused by infection, inflammation, or alternate triggers that is associated with a brain response that leads to these symptoms. The purpose of this study is to examine specific neurologic, immunologic, rheumatologic, and genomic, components in children with the acute-onset of psychiatric symptoms. This research may begin to uncover a much larger story of autoimmune processes that are involved in psychiatric disorders of childhood. By better understanding the etiologic components of psychiatric phenomenon, future treatments may be better targeted to underlying causes.
Key Dates
- Start date
- Mar 31, 2013
- Status verified
- Oct 2016
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: PANS group500 children, 1-18 years old at onset with a strict diagnosis of PANS/PANDAS will be recruited
- Arm: Health Controls100 healthy children age- and gender- matched to the PANS group will be recruited
Primary Outcome Measure
Cerebral blood flow [ Time Frame: Through study completion, up to 12 years ]
Central Contacts
- Joanne Cheung
- Ellen Spartz
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University | Palo Alto | California | 94305-5906 | Joanne Cheung |
Find similar trials in Palo Alto, CA
Related Studies
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Patterns of Neurodevelopmental DisordersRecruiting · Richard Frye · Phoenix, Arizona
- PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus StudyRecruiting · University of Wisconsin, Madison · Lebanon, New Hampshire